Skip to main content
. 2021 Feb 17;28(6):1265–1269. doi: 10.1093/jamia/ocaa343

Table 1.

Phenotypes used in the study. Additional concept unique identifiers (CUIs) for each phenotype are listed in Supplementary Table 1. The last column indicates whether validation was performed against unlabeled subjects in the biobank whose charts were manually reviewed or against a registry cohort

Phenotype Phecode CUIs a (Primary and Secondary) Type of Validation Data
Asthma 495. C0004096, C0038218 Manually reviewed charts
Crohn disease 555.1 C0010346, C0156147 Manually reviewed charts
Ulcerative colitis 555.2 C0009324, C2937222 Manually reviewed charts
Cardiomyopathy 425. C0878544, C0007194 Manually reviewed charts
Congestive heart failure; nonhypertensive 428. C0018802, C0018801 Manually reviewed charts
Epilepsy, recurrent seizures, convulsions 345.

C0014544, C0009951

Manually reviewed charts
Juvenile rheumatoid arthritis 714.2 C0553662, C0157917 Manually reviewed charts
Chronic pulmonary heart disease 415.2 C0152171, C0238074 Manually reviewed charts
Type 1 diabetes 250.1 C0011854, C0375114 Manually reviewed charts
Cardiac congenital anomalies 747.1 C0041207, C0018818 Registry cohort & Manually reviewed charts
Inflammatory bowel disease 555.

C0010346, C0009324

Registry cohort
a

Unified Medical Language System Release 2012AA.